Erste Asset Management’s Novavax NVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-17,600
Closed -$3.68M 523
2021
Q2
$3.68M Sell
17,600
-11,900
-40% -$2.18M 0.07% 240
2021
Q1
$5.11M Buy
+29,500
New +$5.88M 0.13% 176

Other funds holding NVAX

Erste Asset Management's NVAX Position: Q3 2021 in Review

Erste Asset Management sold out of Novavax (NVAX) in Q3 2021, closing a stake of 17,600 shares — an estimated $3.68M sold.

Erste Asset Management first reported a position in NVAX in Q1 2021 and held it in 2 quarters. The position peaked at $5.11M in Q1 2021. 442 funds tracked by Wall St. Rank hold NVAX as of Q3 2021.

  • Erste Asset Management reported no remaining Novavax position as of Q3 2021 after selling out during the quarter.
  • Erste Asset Management sold 17,600 Novavax shares in Q3 2021, an estimated $3.68M.
  • Erste Asset Management first reported a position in Novavax in Q1 2021 and held it in 2 quarters.
  • Erste Asset Management's Novavax position peaked at $5.11M in Q1 2021.
  • 442 funds tracked by Wall St. Rank held Novavax as of Q3 2021.

Based on Erste Asset Management's 13F filing for Q3 2021, filed 25 Nov 2024.